Pharma

Your Article Summary

See Latest Articles

Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA (methylphenidate transdermal system) patches announced
FDA Drug Alerts, 03/24/09

Shire plc, the global specialty biopharmaceutical company, announced today a voluntary market withdrawal/recall of thirty-nine lots of the ADHD patch DAYTRANA. Shire is taking this action because some DAYTRANA patches no longer meet their release liner removal specification, and as a result, patients and caregivers could have difficulties removing the liners.

Today in Marketing/Media/ROI...keeping you current

Receive free subspecialty "5-minute updates" via email

Go Go Generics
PharmExec, 12/18/09

MediciNova and Avigen Stockholders Approve Merger
Avigen, 12/18/09

Almirall and Forest Laboratories to Expand Respiratory Collaboration with LAS100977
Forest Laboratories, 12/18/09

 See all of Marketing/Media/ROI

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

Two Delivery Systems Win Baldrige Award
HealthDataManagement, 12/18/09

Advisory Committee briefing materials for CRESTOR sNDA available on US FDA web site
AstraZeneca, 12/15/09

Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09

 See all of Regulatory Issues